Let's start with a few quick basics about what goes wrong in RA and then have a look at how biologics work to help correct it. ALLAN GIBOFSKY: In rheumatoid arthritis, a person's immune system ...

Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

A safe and effective oral drug would threaten several multibillion-dollar biologic franchises, not only in rheumatoid arthritis but also in several other autoimmune conditions, including Crohn's ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

But looking back at the time, when all we could do was to suppress the pain, there has been great advancements in treating rheumatoid arthritis.

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

Study links systemic inflammation, marked by high CRP and ESR, to interstitial lung disease risk in rheumatoid arthritis, ...